Literature DB >> 34916233

Surprising genetic and pathological findings in a patient with giant bilateral periadrenal tumours: PEComas and mutations of PTCH1 in Gorlin-Goltz syndrome.

Peter Igaz1,2,3, Geza Toth4, Peter Nagy5, Katalin Dezső5, Peter Istvan Turai6,2,3, Marta Medvecz7, Norbert Wikonkal7, Gergely Huszty8, László Piros8, Erika Toth9, Aniko Bozsik10,11, István Likó10, Attila Patócs10,11,12, Henriett Butz10,11,12.   

Abstract

Gorlin-Goltz syndrome (GGS) or nevoid basal cell carcinoma syndrome is a rare tumour-overgrowth syndrome associated with multiple developmental anomalies and a wide variety of tumours. Here, we describe a case of a man aged 23 years with GGS with bilateral giant tumours adjacent to both adrenals that raised the suspicion of malignancy on imaging. Histological analysis of both surgically resected tumours revealed perivascular epitheloid cell tumours (PEComas) that were independent of the adrenals. Exome sequencing of the patient's blood sample revealed a novel germline heterozygous frameshift mutation in the PTCH1 gene. As a second hit, a somatic five nucleotide long deletion in the PTCH1 gene was demonstrated in the tumour DNA of both PEComas. To the best of our knowledge, this is the first report on PEComa in GGS, and this finding also raises the potential relevance of PTCH1 mutations and altered sonic hedgehog signalling in PEComa pathogenesis. The presence of the same somatic mutation in the bilateral tumours might indicate the possibility of a postzygotic somatic mutation that along with the germline mutation of the same gene could represent an intriguing genetic phenomenon (type 2 segmental mosaicism). © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  genetics; medical; medical oncology

Mesh:

Substances:

Year:  2021        PMID: 34916233     DOI: 10.1136/jmedgenet-2021-108082

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   5.941


  1 in total

1.  Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53.

Authors:  Henriett Butz; József Lövey; Márton Szentkereszty; Anikó Bozsik; Erika Tóth; Attila Patócs
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.